[Purpura after application of a eutectic mixture of local anesthetic].
Cervigón
I
I
Torres-Iglesias
L M
LM
Palomo
A
A
D000279:Administration, Cutaneous; D019162:Anesthetics, Combined / Q000008:administration & dosage / Q000009:adverse effects* / Q000493:pharmacokinetics / Q000627:therapeutic use; D000779:Anesthetics, Local / Q000008:administration & dosage / Q000009:adverse effects* / Q000493:pharmacokinetics / Q000627:therapeutic use; D003475:Curettage; D003876:Dermatitis, Atopic / Q000150:complications; D003879:Dermatologic Agents / Q000008:administration & dosage / Q000009:adverse effects* / Q000493:pharmacokinetics / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007223:Infant; D008012:Lidocaine / Q000008:administration & dosage / Q000009:adverse effects* / Q000493:pharmacokinetics / Q000627:therapeutic use; D000077442:Lidocaine, Prilocaine Drug Combination; D008297:Male; D008976:Molluscum Contagiosum / Q000150:complications / Q000601:surgery; D009779:Occlusive Dressings; D009824:Ointments; D011318:Prilocaine / Q000008:administration & dosage / Q000009:adverse effects* / Q000493:pharmacokinetics / Q000627:therapeutic use; D011693:Purpura / Q000139:chemically induced*; D012869:Skin Absorption
D019162:Anesthetics, Combined; D000779:Anesthetics, Local; D003879:Dermatologic Agents; D000077442:Lidocaine, Prilocaine Drug Combination; D009824:Ointments; D011318:Prilocaine; D008012:Lidocaine